We are live on ! Find out more
NMTC icon

NeuroOne Medical Technologies
NMTC

16 hedge funds and large institutions have $3.77M invested in NeuroOne Medical Technologies in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 1

282% more capital invested

Capital invested by funds: $989K → $3.77M (+$2.79M)

129% more funds holding

Funds holding: 7 → 16 (+9)

1.66% more ownership

Funds ownership: 0.35% → 2% (+1.7%)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
16
Holders Change
+9
Holders Change %
+128.57%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
1
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$1.34M
2
ACM
AIGH Capital Management
Maryland
+$1.28M
3
BL
Bleichroeder LP
New York
+$1.01M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$586K
5
WVP
Worth Venture Partners
New Jersey
+$294K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$246K
2
PAM
Premier Asset Management
Illinois
-$197K
3
HF
HRT Financial
New York
-$70.9K
4
TRCT
Tower Research Capital (TRC)
New York
-$12.5K
5
CG
Cutler Group
California
-$534
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$967K +$1.34M +83,059 New
ACM
2
AIGH Capital Management
Maryland
$921K +$1.28M +79,167 New
BL
3
Bleichroeder LP
New York
$728K +$1.01M +62,500 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$421K +$586K +36,205 New
WVP
5
Worth Venture Partners
New Jersey
$211K +$294K +18,161 New
EVC
6
Eidelman Virant Capital
Missouri
$146K +$202K +12,500 New
DWM
7
Drive Wealth Management
Utah
$129K +$180K +11,111 New
IC
8
Intersect Capital
California
$97K – – –
AC
9
Aristides Capital
Kentucky
$71K +$99.2K +6,133 New
Northern Trust
10
Northern Trust
Illinois
$30K +$41.5K +2,563 New
Millennium Management
11
Millennium Management
New York
$29K -$246K -15,217 -86%
HF
12
HRT Financial
New York
$24K -$70.9K -4,382 -67%
TRCT
13
Tower Research Capital (TRC)
New York
$1K -$12.5K -770 -94%
PAM
14
Premier Asset Management
Illinois
– -$197K -8,333 Closed
CG
15
Cutler Group
California
– -$534 -33 -40%
Wells Fargo
16
Wells Fargo
California
– +$65 +4 +44%
Fidelity Investments
17
Fidelity Investments
Massachusetts
– +$113 +7 New

NMTC Hedge Fund Activity: Q4 2021 in Review

16 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NeuroOne Medical Technologies (NMTC) for Q4 2021, worth a combined $3.77M — up 282% from $989K a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new NMTC positions and 1 closed out — a net gain of 9 holders — while 1 added to existing stakes and 4 trimmed.

The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $1.34M. The largest seller was Millennium Management, cutting an estimated $246K.

  • 16 institutional investors held NeuroOne Medical Technologies (NMTC) as of Q4 2021, up from 7 in Q3 2021.
  • Funds reported $3.77M of NeuroOne Medical Technologies stock for Q4 2021, up 282% quarter-over-quarter.
  • 10 funds opened new NeuroOne Medical Technologies positions in Q4 2021 and 1 closed out, a net change of +9 holders.
  • The largest NeuroOne Medical Technologies buyer in Q4 2021 was Stonepine Capital Management, an estimated $1.34M added.
  • The largest NeuroOne Medical Technologies seller in Q4 2021 was Millennium Management, an estimated $246K sold.

Based on aggregated 13F filings for Q4 2021.